Original Research
Accepted on 17 Feb 2025
Iron content of glioblastoma tumours and role of ferrous iron in the hypoxic response in vitro
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1536549
Type at least 3 characters
1,352 articles
Articles
Original Research
Accepted on 14 Feb 2025
IGV-001 Cellular Immunotherapy for Newly Diagnosed Glioblastoma: Overcoming the Logistic Challenge
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1556450
- 121 views
Original Research
Accepted on 13 Feb 2025
Integrative multi-omic profiling of the neoantigen landscape of glioblastoma for the development of therapeutic vaccines reveals vast heterogeneity in immunogenic signatures
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1507632
Original Research
Accepted on 11 Feb 2025
The velocity of temporalis muscle wasting in cerebral metastasis is prognostic for poor survival.
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1482705
Case Report
Published on 11 Feb 2025
Primary leiomyosarcoma of the scalp: a case report and review of the literature
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1533114
- 142 views
Original Research
Published on 11 Feb 2025
ATP1B3 may promote glioma proliferation and migration through MAPK/NF-KB signaling pathway
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1537687
- 155 views
Case Report
Published on 10 Feb 2025
Case report: From misdiagnosis to timely detection: a clinical and imaging guide to neurological presentations of diffuse large B-cell lymphoma—insights from six cases
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1410953
- 227 views
Case Report
Published on 10 Feb 2025
Case report: an unusual long-term evolution of a diffuse midline glioma, H3K27 altered
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1480247
- 234 views
Case Report
Published on 10 Feb 2025
Progression and diagnostic challenges of desmoplastic infantile ganglioglioma in a non-infant: a case report with 5-year follow-up
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1411213
- 103 views
Mini Review
Accepted on 07 Feb 2025
Identifying new therapeutics for focused ultrasound-enhanced drug delivery in the management of glioblastoma
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1507940
- 119 views
Case Report
Accepted on 07 Feb 2025
Vestibular Scwhannomas and Papilledema without Hydrocephalus: a Case Report
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1448374
Original Research
Published on 07 Feb 2025
Research trends in glioma chemoradiotherapy resistance: a bibliometric analysis (2003–2023)
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1539937
- 191 views
Original Research
Accepted on 05 Feb 2025
Photodynamic therapy and tumor-treating fields therapy for newly diagnosed glioblastoma
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1556669
Editorial
Published on 05 Feb 2025
Editorial: Updates on the management of glioblastoma
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1526669
- 345 views
Original Research
Published on 04 Feb 2025
Risk factors for motor decline following parasagittal and falx meningioma resection in the middle third
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1458934
- 207 views
Case Report
Published on 04 Feb 2025
Case report: A rare case of a long-term survivor of glioblastoma who underwent two courses of hypofractionated radiotherapy as part of her care
in Neuro-Oncology and Neurosurgical Oncology
Frontiers in Oncology
doi 10.3389/fonc.2025.1501466
- 210 views